Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cullell-Young

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2011
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancerM D Michaelson, J Bellmunt, G R Hudes, et al.
Cancer Chemotherapy and Pharmacology|May 7, 2013
Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumorsR Salazar, H Cortés-Funes, E Casado, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2011
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancerM D Michaelson, J Bellmunt, G R Hudes, et al.
Cancer Chemotherapy and Pharmacology|May 7, 2013
Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumorsR Salazar, H Cortés-Funes, E Casado, et al.
Pageof 2